Oral Delivery of Novel Recombinant <i>Lactobacillus</i> Elicit High Protection against <i>Staphylococcus aureus</i> Pulmonary and Skin Infections.

Vaccines (Basel) · 2021 · PMC8473125 · PMID 34579221

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differences with p < 0.05 and p < 0.01 were considered to be significant and highly significant, respectively. 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.